PORTAGE BIOTECH INC (PRTG) Stock Price, Quote, News and Overview
NASDAQ:PRTG - Nasdaq - VGG7185A1369 - Common Stock - Currency: USD
PRTG Quote, Performance and Key Statistics
8.45
-0.82 (-8.85%)
The current stock price of PRTG is 8.45 USD. In the past month the price increased by 79.41%. In the past year, price increased by 75.9%.
PRTG Competitors/Peers
Symbol | Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| ABBV | ABBVIE INC | 18.39 | 329.14B | ||
| AMGN | AMGEN INC | 14.17 | 150.99B | ||
| GILD | GILEAD SCIENCES INC | 13.33 | 128.61B | ||
| VRTX | VERTEX PHARMACEUTICALS INC | 1702.9 | 126.96B | ||
| REGN | REGENERON PHARMACEUTICALS | 13.2 | 65.88B | ||
| ARGX | ARGENX SE - ADR | 330.52 | 37.54B | ||
| ALNY | ALNYLAM PHARMACEUTICALS INC | N/A | 32.72B | ||
| ONC | BEIGENE LTD-ADR | N/A | 26.39B | ||
| BNTX | BIONTECH SE-ADR | N/A | 24.52B | ||
| NTRA | NATERA INC | N/A | 20.79B | ||
| BIIB | BIOGEN INC | 7.22 | 17.39B | ||
| SMMT | SUMMIT THERAPEUTICS INC | N/A | 17.30B |
Related stock screener links
About PRTG
Company Profile
Portage Biotech, Inc. is a biotechnology company, which engages in the research and development of immuno-oncology therapies for patients with cancer. The firm is engaged in advancing therapies to improve long-term treatment response, and quality of life in patients with cancers. The Company’s access to technologies coupled with biological mechanisms enables the identification of clinical therapies and product development strategies, which accelerate these medicines through the translational pipeline. The Company’s portfolio consists of four platforms, with lead programs consisting of invariant natural killer T-cell (iNKT) engagers and a suite of treatments targeting the adenosine pathway. Within these four platforms, the Company has nine product candidates, of which five are pre-clinical and four of which are clinical stage. The Company’s portfolio also includes small molecule adenosine inhibitors, such as PORT-6, PORT-7, PORT-8 and PORT-9, which represent targeting the adenosine pathway.
Company Info
PORTAGE BIOTECH INC
Clarence Thomas Building, P.O. Box 4649, Road Town
Tortola ONTARIO VG1110 VG
CEO: Ian Walters
Employees: 7
Company Website: https://portagebiotech.com/
Investor Relations: http://ir.portagebiotech.com
Phone: 4167377600
PORTAGE BIOTECH INC / PRTG FAQ
What is the stock price of PORTAGE BIOTECH INC today?
The current stock price of PRTG is 8.45 USD. The price decreased by -8.85% in the last trading session.
What is the ticker symbol for PORTAGE BIOTECH INC stock?
The exchange symbol of PORTAGE BIOTECH INC is PRTG and it is listed on the Nasdaq exchange.
On which exchange is PRTG stock listed?
PRTG stock is listed on the Nasdaq exchange.
What is PORTAGE BIOTECH INC worth?
PORTAGE BIOTECH INC (PRTG) has a market capitalization of 13.94M USD. This makes PRTG a Nano Cap stock.
How many employees does PORTAGE BIOTECH INC have?
PORTAGE BIOTECH INC (PRTG) currently has 7 employees.
What are the support and resistance levels for PORTAGE BIOTECH INC (PRTG) stock?
PORTAGE BIOTECH INC (PRTG) has a support level at 5.9 and a resistance level at 9.58. Check the full technical report for a detailed analysis of PRTG support and resistance levels.
Should I buy PORTAGE BIOTECH INC (PRTG) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of PRTG, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of PRTG, evaluating the profitability, health, valuation and growth aspects
- PORTAGE BIOTECH INC (PRTG) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- PORTAGE BIOTECH INC (PRTG) Sales and EPS estimates to see what analysts future expectations are.
- PORTAGE BIOTECH INC (PRTG) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- PORTAGE BIOTECH INC (PRTG) Insider and Institutional Ownership to learn about the owners and their transactions.
- PORTAGE BIOTECH INC (PRTG) Stock Chart to make your own analysis
- PORTAGE BIOTECH INC (PRTG) Latest news and press-releases to stay up to date.
Does PORTAGE BIOTECH INC (PRTG) stock pay dividends?
PRTG does not pay a dividend.
When does PORTAGE BIOTECH INC (PRTG) report earnings?
PORTAGE BIOTECH INC (PRTG) will report earnings on 2025-08-13, after the market close.
What is the Price/Earnings (PE) ratio of PORTAGE BIOTECH INC (PRTG)?
PORTAGE BIOTECH INC (PRTG) does not have a PE ratio as the earnings reported over the last twelve months were negative (-129.8).
What is the Short Interest ratio of PORTAGE BIOTECH INC (PRTG) stock?
The outstanding short interest for PORTAGE BIOTECH INC (PRTG) is 1.73% of its float. Check the ownership tab for more information on the PRTG short interest.
PRTG Technical Analysis
ChartMill assigns a technical rating of 9 / 10 to PRTG. When comparing the yearly performance of all stocks, PRTG is one of the better performing stocks in the market, outperforming 98.32% of all stocks.
PRTG Fundamental Analysis
ChartMill assigns a fundamental rating of 2 / 10 to PRTG. While PRTG seems to be doing ok healthwise, there are quite some concerns on its profitability.
PRTG Financial Highlights
Over the last trailing twelve months PRTG reported a non-GAAP Earnings per Share(EPS) of -129.8. The EPS decreased by -403.1% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -1357.19% | ||
| ROE | -2830.59% | ||
| Debt/Equity | 0 |
PRTG Ownership and Analysts
ChartMill assigns a Buy % Consensus number of 43% to PRTG. The Buy consensus is the average rating of analysts ratings from 6 analysts.